Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVistry Grp Regulatory News (VTY)

Share Price Information for Vistry Grp (VTY)

Share Price is delayed by 15 minutes
Get Live Data
257.60    -4.80 (-1.83%)
Bid:
257.80
Ask:
258.40
Spread: 0.60 (0.233%)
Market Cap: £818.12m
VTY Live PriceLast checked at - London Stock Exchange

Intraday Vistry Grp Share Chart

Update on EGM Remuneration Report Vote

21 Feb 2024 07:00

RNS Number : 8072D
Vistry Group PLC
21 February 2024
 

21 February 2024

Vistry Group PLC ('Company' or 'Vistry')

Update on Extraordinary General Meeting Remuneration Report vote

At the Company's extraordinary general meeting ('EGM') held on 30 August 2023, 54.80% of votes were received in favour of Resolution 1, to approve the revised remuneration policy and 55.28% of votes were received in favour of Resolution 2, to approve amendments to the LTIP implementing the revised policy.

In the six months prior to the EGM the Remuneration Committee ("Committee") was focussed on developing a remuneration framework that reflected a business of the size and scope of Vistry following the combination with Countryside in 2022. The Committee considered various approaches to remuneration and following extensive shareholder engagement the Committee determined to amend the remuneration policy, leveraging the existing structure and performance measures to provide alignment with the strategy, our shareholders and other stakeholders.

The amendments to the policy were set out in detail in the Notice of General Meeting. In summary, the proposals increased the maximum bonus and LTIP opportunity to 300% of base salary and strengthened long-term alignment with our shareholders through increased bonus deferral, strengthened deferred bonus leaver conditions, and increased shareholding guidelines. The amendments have been applied for the CEO only to date.

The Committee understands that the reasons for the number of votes cast against was primarily concerned with the step up in maximum opportunity for the CEO which was in excess of usual levels within the FTSE 250. The Committee acknowledges these concerns; however they maintain their view that the positioning of remuneration under the new policy is aligned with a framework that is highly performance orientated, and emphasises variable, equity-based remuneration designed to incentivise growth and creation of shareholder value over the long term.

The Committee is grateful to shareholders for their engagement and acknowledges that through the engagement process shareholders have expressed different perspectives. The Company remains committed to ongoing shareholder engagement and will continue to do so to ensure that the Company understands shareholders' views and is able to consider feedback, as well as to provide clarity on the Company's approach to remuneration going forward. The Chair of the Committee shall write to shareholders following the publication of the 2023 Annual Report and Accounts to explain the remuneration decisions that have been made for 2023 as well as providing details on the implementation of our Policy in 2024.

 

Vistry Group PLC

Clare Bates, General Counsel & Group Company Secretary

 

 

01675 437160

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFISFTIIFIS
Date   Source Headline
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSH1 2025 Trading Update
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:15 amRNSCMA consults on proposed voluntary commitments
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 202510:00 amRNSCapital Reduction becomes effective
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSShare buyback – management of the programme
30th Jun 20255:30 pmRNSTotal Voting Rights
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20255:00 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20255:30 pmRNSTotal Voting Rights
30th May 20254:30 pmRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20254:30 pmRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSTransaction in Own Shares
15th May 202511:00 amRNSResult of AGM - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.